Reverse payment settlements in the European Union after the Generics (UK) judgment – perplexing legal uncertainty

Reverse payment settlements in the European Union after the Generics (UK) judgment – perplexing legal uncertainty

By Tommi Lahtinen and Victor Pierre On January 30th, the Court of Justice (“the Court”) released its judgment in the Generics (UK) case. In a preliminary ruling procedure, the UK Competition Appeal Tribunal asked the Court to provide guidance on how to interpret Article 101 TFEU with regard to patent settlements between pharmaceutical companies. The judgment has considerable legal significance […]